Kalehua Capital Management LLC
Clone Performance
Feb 2026–Aug 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends; a captured split can shorten the simulated window. It tracks 100% of reported value on average across 3 quarters. Past performance does not predict future results.
Portfolio Concentration
25 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $147,480,687 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GOSS | Gossamer Bio, Inc. | +3,677,523 | 11,149,363 | $1,839,644 | |
| IKT | Inhibikase Therapeutics, Inc. | +1,149,282 | 3,821,890 | $7,758,436 | |
| ACRS | Aclaris Therapeutics, Inc. | +494,809 | 1,832,365 | $9,693,210 | |
| KRRO | Korro Bio, Inc. | +295,664 | 405,040 | $5,338,427 | |
| MANE | Veradermics, Inc | +42,816 | 145,695 | $17,911,743 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | 685,644 | $6,698,741 | |
| IFRX | InflaRx N.V. | 2,897,769 | $6,491,002 | |
| CYCN | Cyclerion Therapeutics, Inc. | 1,651,350 | $5,598,076 | |
| ANL | Adlai Nortye Ltd. | 226,415 | $2,603,772 | |
| NVCT | Nuvectis Pharma, Inc. | 100,000 | $1,839,000 | |
| MIST | Milestone Pharmaceuticals Inc. | 1,269,237 | $1,700,777 | |
| ATYR | aTYR PHARMA INC | 1,788,167 | $1,067,535 | |
| TCRX | TScan Therapeutics, Inc. | 454,876 | $445,778 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | 901,457 | $8,969,497 | |
| ORKA | Oruka Therapeutics, Inc. | 118,524 | $5,813,602 | |
| TNYA | Tenaya Therapeutics, Inc. | 2,000,000 | $1,384,000 | |
| PEPG | PepGen Inc. | 729,961 | $1,292,030 | |
| KLRS | Kalaris Therapeutics, Inc. | 135,585 | $782,325 | |
| LOOP | Loop Industries, Inc. | 347,539 | $496,980 | |
| DMAC | DiaMedica Therapeutics Inc. | 62,488 | $423,043 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| MANE |
Veradermics, Inc
Healthcare
|
Added | 145,695 | $17,911,743 | 12.15% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Held | 3,722,840 | $17,385,662 | 11.79% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Held | 819,692 | $11,598,641 | 7.86% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Held | 385,178 | $9,995,369 | 6.78% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Added | 1,832,365 | $9,693,210 | 6.57% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Held | 197,072 | $8,669,197 | 5.88% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Added | 3,821,890 | $7,758,436 | 5.26% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 198,772 | $6,873,535 | 4.66% | |
| KPTI |
Karyopharm Therapeutics Inc.
Healthcare
|
NEW | 685,644 | $6,698,741 | 4.54% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 194,544 | $6,515,278 | 4.42% | |
| IFRX |
InflaRx N.V.
Healthcare
|
NEW | 2,897,769 | $6,491,002 | 4.40% | |
| CYCN |
Cyclerion Therapeutics, Inc.
Healthcare
|
NEW | 1,651,350 | $5,598,076 | 3.80% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
Added | 405,040 | $5,338,427 | 3.62% | |
| QURE |
uniQure N.V.
Healthcare
|
Reduced | 79,407 | $3,657,486 | 2.48% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
Held | 393,701 | $3,618,112 | 2.45% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
Held | 139,000 | $3,615,390 | 2.45% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Held | 175,734 | $3,421,540 | 2.32% | |
| ANL |
Adlai Nortye Ltd.
Healthcare
|
NEW | 226,415 | $2,603,772 | 1.77% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 74,465 | $2,378,412 | 1.61% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
Added | 11,149,363 | $1,839,644 | 1.25% | |
| NVCT |
Nuvectis Pharma, Inc.
Healthcare
|
NEW | 100,000 | $1,839,000 | 1.25% | |
| MIST |
Milestone Pharmaceuticals Inc.
Healthcare
|
NEW | 1,269,237 | $1,700,777 | 1.15% | |
| ATYR |
aTYR PHARMA INC
Healthcare
|
NEW | 1,788,167 | $1,067,535 | 0.72% | |
| TIL |
Instil Bio, Inc.
Healthcare
|
Reduced | 99,600 | $765,924 | 0.52% | |
| TCRX |
TScan Therapeutics, Inc.
Healthcare
|
NEW | 454,876 | $445,778 | 0.30% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.